CAR-MSC 的最新进展:细胞免疫治疗演化的新引擎
Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution.
ALL SOURCES
Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution.
Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration.
The potential of B7-H3 as a new target for CAR-T therapy: Advancements, challenges and clinical perspectives.
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.
Unconventional T cells in anti-cancer immunity.
An update on the clinical trial research of immunotherapy for glioblastoma.
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance.
Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy.
Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。